| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_29a7aa981dcfe4b0b8a33e822b062da6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9fb7bbc09927d64558e1e99a3b7c719b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-70596 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0032
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-549
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56966
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-0491
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K51-065 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-61
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2014-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d006f0e67be3572ef4519bc09d598428
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42eea0f7cd3bc7d1c25b93bdfbe5bbb4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8f8f766c4fb38c5e45d870a5a1647198
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c866b9794a3917e908373c9cca53150d |
| publicationDate |
2021-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210095972-A |
| titleOfInvention |
Compositions, methods and kits for diagnosing and treating cd206 expressing cell-related disorders |
| abstract |
The present invention relates to a method for diagnosing a CD206 expressing cell-associated disorder by administering to a subject a pharmaceutical composition comprising a carrier molecule having a detectable moiety attached thereto. The carrier molecule comprises a dextran backbone and one or more receptor substrates that are directly or indirectly conjugated to the dextran backbone and are selected to specifically bind CD206. Also provided are methods for treating CD206 expressing cell-associated disorders, as well as ex vivo methods and kits for quantifying the number of CD206 expressing cells in a body fluid. |
| priorityDate |
2013-07-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |